HEROUX-DEVTEK INC (HRX.CA) Fundamental Analysis & Valuation

TSX:HRX • CA42774L1094

Current stock price

32.48 CAD
0 (0%)
Last:

This HRX.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. HRX.CA Profitability Analysis

1.1 Basic Checks

  • HRX had positive earnings in the past year.
  • In the past year HRX had a positive cash flow from operations.
  • HRX had positive earnings in 4 of the past 5 years.
  • In the past 5 years HRX always reported a positive cash flow from operatings.
HRX.CA Yearly Net Income VS EBIT VS OCF VS FCFHRX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

  • With an excellent Return On Assets value of 5.44%, HRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 11.12%, HRX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • HRX's Return On Invested Capital of 9.02% is in line compared to the rest of the industry. HRX outperforms 54.55% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HRX is below the industry average of 9.52%.
  • The 3 year average ROIC (5.23%) for HRX is below the current ROIC(9.02%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.44%
ROE 11.12%
ROIC 9.02%
ROA(3y)3.29%
ROA(5y)1.33%
ROE(3y)7.02%
ROE(5y)2.36%
ROIC(3y)5.23%
ROIC(5y)5.49%
HRX.CA Yearly ROA, ROE, ROICHRX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

  • HRX's Profit Margin of 7.51% is amongst the best of the industry. HRX outperforms 100.00% of its industry peers.
  • HRX's Profit Margin has improved in the last couple of years.
  • With an excellent Operating Margin value of 11.55%, HRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • HRX's Operating Margin has been stable in the last couple of years.
  • HRX has a Gross Margin of 20.10%. This is amonst the worse of the industry: HRX underperforms 81.82% of its industry peers.
  • HRX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.55%
PM (TTM) 7.51%
GM 20.1%
OM growth 3Y2.73%
OM growth 5Y0.29%
PM growth 3Y19.94%
PM growth 5Y2.18%
GM growth 3Y1.98%
GM growth 5Y0.51%
HRX.CA Yearly Profit, Operating, Gross MarginsHRX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. HRX.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HRX is still creating some value.
  • Compared to 1 year ago, HRX has less shares outstanding
  • The number of shares outstanding for HRX has been reduced compared to 5 years ago.
  • HRX has a worse debt/assets ratio than last year.
HRX.CA Yearly Shares OutstandingHRX.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
HRX.CA Yearly Total Debt VS Total AssetsHRX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • HRX has an Altman-Z score of 3.21. This indicates that HRX is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of HRX (3.21) is better than 100.00% of its industry peers.
  • HRX has a debt to FCF ratio of 6.40. This is a slightly negative value and a sign of low solvency as HRX would need 6.40 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 6.40, HRX belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
  • A Debt/Equity ratio of 0.26 indicates that HRX is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.26, HRX is doing good in the industry, outperforming 72.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 6.4
Altman-Z 3.21
ROIC/WACC1.14
WACC7.94%
HRX.CA Yearly LT Debt VS Equity VS FCFHRX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • HRX has a Current Ratio of 2.13. This indicates that HRX is financially healthy and has no problem in meeting its short term obligations.
  • HRX has a Current ratio of 2.13. This is amongst the best in the industry. HRX outperforms 90.91% of its industry peers.
  • A Quick Ratio of 0.68 indicates that HRX may have some problems paying its short term obligations.
  • HRX's Quick ratio of 0.68 is fine compared to the rest of the industry. HRX outperforms 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 0.68
HRX.CA Yearly Current Assets VS Current LiabilitesHRX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. HRX.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 212.24% over the past year.
  • Measured over the past 5 years, HRX shows a small growth in Earnings Per Share. The EPS has been growing by 4.72% on average per year.
  • Looking at the last year, HRX shows a quite strong growth in Revenue. The Revenue has grown by 19.98% in the last year.
  • The Revenue has been growing slightly by 5.41% on average over the past years.
EPS 1Y (TTM)212.24%
EPS 3Y8.44%
EPS 5Y4.72%
EPS Q2Q%171.43%
Revenue 1Y (TTM)19.98%
Revenue growth 3Y3.34%
Revenue growth 5Y5.41%
Sales Q2Q%22.37%

3.2 Future

  • Based on estimates for the next years, HRX will show a very strong growth in Earnings Per Share. The EPS will grow by 29.83% on average per year.
  • HRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.02% yearly.
EPS Next Y53.48%
EPS Next 2Y37.88%
EPS Next 3Y29.83%
EPS Next 5YN/A
Revenue Next Year16.19%
Revenue Next 2Y11.66%
Revenue Next 3Y9.02%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HRX.CA Yearly Revenue VS EstimatesHRX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
HRX.CA Yearly EPS VS EstimatesHRX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. HRX.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 21.23, the valuation of HRX can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of HRX is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 24.88. HRX is around the same levels.
  • HRX is valuated correctly with a Price/Forward Earnings ratio of 16.75.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HRX is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of HRX to the average of the S&P500 Index (22.19), we can say HRX is valued slightly cheaper.
Industry RankSector Rank
PE 21.23
Fwd PE 16.75
HRX.CA Price Earnings VS Forward Price EarningsHRX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • HRX's Enterprise Value to EBITDA is on the same level as the industry average.
  • Based on the Price/Free Cash Flow ratio, HRX is valued a bit more expensive than the industry average as 72.73% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 50.16
EV/EBITDA 10.59
HRX.CA Per share dataHRX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • HRX has a very decent profitability rating, which may justify a higher PE ratio.
  • HRX's earnings are expected to grow with 29.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.4
PEG (5Y)4.5
EPS Next 2Y37.88%
EPS Next 3Y29.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HRX.CA Dividend Analysis

5.1 Amount

  • No dividends for HRX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

HRX.CA Fundamentals: All Metrics, Ratios and Statistics

HEROUX-DEVTEK INC

TSX:HRX (2/13/2025, 7:00:00 PM)

32.48

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-12
Earnings (Next)02-24
Inst Owners16.57%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap1.09B
Revenue(TTM)694.73M
Net Income(TTM)52.18M
Analysts47.5
Price Target30.86 (-4.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)41.29%
Min EPS beat(2)23.36%
Max EPS beat(2)59.23%
EPS beat(4)4
Avg EPS beat(4)50.28%
Min EPS beat(4)23.36%
Max EPS beat(4)62.02%
EPS beat(8)6
Avg EPS beat(8)23.09%
EPS beat(12)8
Avg EPS beat(12)12.44%
EPS beat(16)12
Avg EPS beat(16)17.01%
Revenue beat(2)2
Avg Revenue beat(2)6.82%
Min Revenue beat(2)4.67%
Max Revenue beat(2)8.97%
Revenue beat(4)4
Avg Revenue beat(4)7.24%
Min Revenue beat(4)4.67%
Max Revenue beat(4)8.97%
Revenue beat(8)6
Avg Revenue beat(8)3.62%
Revenue beat(12)8
Avg Revenue beat(12)1.21%
Revenue beat(16)9
Avg Revenue beat(16)0.68%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-3.75%
EPS NQ rev (3m)10%
EPS NY rev (1m)-4.62%
EPS NY rev (3m)-4.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 21.23
Fwd PE 16.75
P/S 1.58
P/FCF 50.16
P/OCF 24.41
P/B 2.33
P/tB 3.85
EV/EBITDA 10.59
EPS(TTM)1.53
EY4.71%
EPS(NY)1.94
Fwd EY5.97%
FCF(TTM)0.65
FCFY1.99%
OCF(TTM)1.33
OCFY4.1%
SpS20.62
BVpS13.93
TBVpS8.45
PEG (NY)0.4
PEG (5Y)4.5
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 5.44%
ROE 11.12%
ROCE 11.39%
ROIC 9.02%
ROICexc 9.03%
ROICexgc 12.25%
OM 11.55%
PM (TTM) 7.51%
GM 20.1%
FCFM 3.14%
ROA(3y)3.29%
ROA(5y)1.33%
ROE(3y)7.02%
ROE(5y)2.36%
ROIC(3y)5.23%
ROIC(5y)5.49%
ROICexc(3y)5.6%
ROICexc(5y)5.99%
ROICexgc(3y)7.74%
ROICexgc(5y)8.37%
ROCE(3y)6.61%
ROCE(5y)6.94%
ROICexgc growth 3Y-0.85%
ROICexgc growth 5Y1.32%
ROICexc growth 3Y0.72%
ROICexc growth 5Y5.43%
OM growth 3Y2.73%
OM growth 5Y0.29%
PM growth 3Y19.94%
PM growth 5Y2.18%
GM growth 3Y1.98%
GM growth 5Y0.51%
F-Score7
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 6.4
Debt/EBITDA 1.05
Cap/Depr 63.68%
Cap/Sales 3.31%
Interest Coverage 7.47
Cash Conversion 38.53%
Profit Quality 41.81%
Current Ratio 2.13
Quick Ratio 0.68
Altman-Z 3.21
F-Score7
WACC7.94%
ROIC/WACC1.14
Cap/Depr(3y)51.91%
Cap/Depr(5y)50.48%
Cap/Sales(3y)3.31%
Cap/Sales(5y)3.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)212.24%
EPS 3Y8.44%
EPS 5Y4.72%
EPS Q2Q%171.43%
EPS Next Y53.48%
EPS Next 2Y37.88%
EPS Next 3Y29.83%
EPS Next 5YN/A
Revenue 1Y (TTM)19.98%
Revenue growth 3Y3.34%
Revenue growth 5Y5.41%
Sales Q2Q%22.37%
Revenue Next Year16.19%
Revenue Next 2Y11.66%
Revenue Next 3Y9.02%
Revenue Next 5YN/A
EBIT growth 1Y146.56%
EBIT growth 3Y6.15%
EBIT growth 5Y5.72%
EBIT Next Year148.95%
EBIT Next 3Y44.43%
EBIT Next 5YN/A
FCF growth 1Y-24.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.24%
OCF growth 3Y-67.96%
OCF growth 5Y-46.98%

HEROUX-DEVTEK INC / HRX.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HEROUX-DEVTEK INC?

ChartMill assigns a fundamental rating of 6 / 10 to HRX.CA.


What is the valuation status of HEROUX-DEVTEK INC (HRX.CA) stock?

ChartMill assigns a valuation rating of 4 / 10 to HEROUX-DEVTEK INC (HRX.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for HEROUX-DEVTEK INC?

HEROUX-DEVTEK INC (HRX.CA) has a profitability rating of 7 / 10.


How financially healthy is HEROUX-DEVTEK INC?

The financial health rating of HEROUX-DEVTEK INC (HRX.CA) is 7 / 10.


What is the expected EPS growth for HEROUX-DEVTEK INC (HRX.CA) stock?

The Earnings per Share (EPS) of HEROUX-DEVTEK INC (HRX.CA) is expected to grow by 53.48% in the next year.